These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14713179)

  • 1. Immediate sheath removal after PCI using a Femostop is feasible and safe. Results of a registry.
    Jaspers L; Benit E
    Acta Cardiol; 2003 Dec; 58(6):535-7. PubMed ID: 14713179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of suture-mediated closure after percutaneous coronary interventions.
    Rinder MR; Tamirisa PK; Taniuchi M; Kurz HI; Mumm K; Lasala JM
    Catheter Cardiovasc Interv; 2001 Oct; 54(2):146-51. PubMed ID: 11590673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro).
    Chamberlin JR; Lardi AB; McKeever LS; Wang MH; Ramadurai G; Grunenwald P; Towne WP; Grassman ED; Leya FS; Lewis BE; Stein LH
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):143-7; discussion 148. PubMed ID: 10376492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the FemoStop device and manual pressure in reducing groin puncture site complications following coronary angioplasty and coronary stent placement.
    Walker SB; Cleary S; Higgins M
    Int J Nurs Pract; 2001 Dec; 7(6):366-75. PubMed ID: 11785439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six hour ambulation after elective coronary angioplasty and stenting with 7F guiding catheters ald low dose heparin.
    Tengiz I; Ercan E; Bozdemir H; Durmaz O; Gurgun C; Nalbantgil I
    Kardiol Pol; 2003 Feb; 58(2):93-7. PubMed ID: 14504634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial experience with a new femoral artery closure device following percutaneous coronary intervention with glycoprotein IIb/IIIa inhibition.
    Ruygrok PN; Ormiston JA; Stewart JT; Webster MW; El Jack S; Simpson-Plaumann S; Kay IP; Chou TM
    Catheter Cardiovasc Interv; 2005 Oct; 66(2):185-91. PubMed ID: 16152652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular access site complications with the use of closure devices in patients treated with platelet glycoprotein IIb/IIIa inhibitors during rescue angioplasty.
    Boccalandro F; Assali A; Fujise K; Smalling RW; Sdringola S
    Catheter Cardiovasc Interv; 2004 Nov; 63(3):284-9. PubMed ID: 15505838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of a 6 French perclose arterial suturing device following percutaneous coronary interventions: a pilot evaluation.
    Kornowski R; Brandes S; Teplitsky I; Rechavia E; Shor N; Battler A; Assali A
    J Invasive Cardiol; 2002 Dec; 14(12):741-5. PubMed ID: 12454337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized comparison of a percutaneous suture device versus manual compression for femoral artery hemostasis after PTCA.
    Tron C; Koning R; Eltchaninoff H; Douillet R; Chassaing S; Sanchez-Giron C; Cribier A
    J Interv Cardiol; 2003 Jun; 16(3):217-21. PubMed ID: 12800399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention.
    Juergens CP; Leung DY; Crozier JA; Wong AM; Robinson JT; Lo S; Kachwalla H; Hopkins AP
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):166-70. PubMed ID: 15390237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of three groin compression methods on patient discomfort, distress, and vascular complications following a percutaneous coronary intervention procedure.
    Chlan LL; Sabo J; Savik K
    Nurs Res; 2005; 54(6):391-8. PubMed ID: 16317360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early sheath removal and ambulation in patients submitted to percutaneous coronary intervention: a randomised clinical trial.
    Augustin AC; de Quadros AS; Sarmento-Leite RE
    Int J Nurs Stud; 2010 Aug; 47(8):939-45. PubMed ID: 20176355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate femoral sheath removal after 6 French routine coronary angioplasty with a weight-adjusted low-dose heparin: results of a prospective registry.
    Metz D; Brasselet C; Tabet E; Nazeyrollas P; Tassan-Mangina S; Deschildre A; Elaerts J; Blaise C
    J Invasive Cardiol; 1999 Jul; 11(7):416-20. PubMed ID: 10745564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of bleeding complications using arterial closure device versus manual compression by propensity matching in patients undergoing percutaneous coronary intervention.
    Allen DS; Marso SP; Lindsey JB; Kennedy KF; Safley DM
    Am J Cardiol; 2011 Jun; 107(11):1619-23. PubMed ID: 21420052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of complications following sheath removal with percutaneous coronary intervention.
    Sulzbach-Hoke LM; Ratcliffe SJ; Kimmel SE; Kolansky DM; Polomano R
    J Cardiovasc Nurs; 2010; 25(3):E1-8. PubMed ID: 20357666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a pneumatic compression system (FemoStop) as a treatment option for femoral artery pseudoaneurysms after percutaneous cardiac procedures.
    Dangas G; Mehran R; Duvvuri S; Ambrose JA; Sharma SK
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):138-42. PubMed ID: 8922313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid hemostasis of arterial puncture sites with Angio-Seal in patients undergoing percutaneous coronary intervention.
    Trisnohadi HB
    Acta Med Indones; 2005; 37(2):87-90. PubMed ID: 20066791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Femoral access management: comparison between two different vascular closure devices after percutaneous coronary intervention.
    Legrand V; Doneux P; Martinez C; Gach O; Bellekens M
    Acta Cardiol; 2005 Oct; 60(5):482-8. PubMed ID: 16261778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early ambulation and variability in anticoagulation during elective coronary stenting with a single intravenous bolus of low-dose, low-molecular weight heparin enoxaparin.
    Zalc S; Lemos PA; Esteves A; Ribeiro EE; Horta P; Nicolau JC; Ramires JA; Cohen M; Martinez EE
    J Invasive Cardiol; 2006 Feb; 18(2):45-8. PubMed ID: 16446514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two hour ambulation after coronary angioplasty and stenting with 6 F guiding catheters and low dose heparin.
    Koch KT; Piek JJ; de Winter RJ; Mulder K; Schotborgh CE; Tijssen JG; Lie KI
    Heart; 1999 Jan; 81(1):53-6. PubMed ID: 10220545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.